Application of surface-enhanced laser desorption/ionization time-of-flight-based serum proteomic array technique for the early diagnosis of retinoblastoma

International Journal of Ophthalmology

Volumn 8, Issue 1, 2008, Pages 1-5

  Zhou, Li Jun ^a   Xiao, Xue Yuan ^b   Wu, Kai Li ^a   Wang, Ju Ling ^b   Yang, Hua Sheng ^a   Li, Yong Ping ^a   He, Da Cheng ^b   Zhang, Ping ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b BEIJING NORMAL UNIVERSITY   (China)

Author keywords

Differential protein; Retinoblastoma; SELDI protein chip

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BIOINFORMATICS; BLOOD ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; DOWN REGULATION; EARLY DIAGNOSIS; FISHER EXACT TEST; GENE EXPRESSION REGULATION; HUMAN; PROTEIN ANALYSIS; PROTEIN MICROARRAY; PROTEOMICS; RETINOBLASTOMA; SENSITIVITY AND SPECIFICITY; STUDENT T TEST; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; UPREGULATION;

EID: 38949149666     PISSN: 16725123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hervás Benito I, Ruiz Rodríguez JC, Saura Quiles A, Borghol Kassar R, Harto MA, Bello Arques P, Sancho Gaspar A, Pérez Pastor JL, Mateo Navarro A. Radioimmunometric assay of neuron specific enolase in aqueous humor and serum in patients with retinoblastoma. Rev Esp Med Nucl 2000;19(7): 472-478
2. Wu ZY, Yang HS, Pan SH. Electrophoretic determination of apueous and serum neuron-specific enolase in the diagnosis of retinoblastoma. Chin J Ophthalmol 1996;32(3):219-223
3. Wadsworth JT, Somers KD, Cazares LH, Malik G, Adam BL, Stack BC Jr, Wright GL Jr, Semmes OJ. Serum protein profiles to identify head and neck cancer. Clin Cancer Res 2004;10:1625-1632
4. Koopmann J, Zhang Z, White N, Rosenzweig J, Fedarko N, Jagannath S, Canto MI, Yeo CJ, Chan DW, Goggins M. Serum diagnosis of pancreatic adenocarcinoma using surface enhanced laser desorption/ionization mass spectrometry. Clin Cancer Res 2004;10:860-868
5. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002; 359:572-577
6. Xiao XY, Wei XP, He DC. Screening of serum biomarker of lung cancer using SELDI-TOF-MS. Sci China Ser C-Life Sci 2003;33:323-328
7. Lumbroso L, Doz F, Urbieta M, Levy C, Bours D, Asselain B, Vedrenne J, Zucker JM, Desjardins L. Chemotherapy in the management of retinoblastoma. Ophthalmology 2002;109:1130-1136
8. Shields CL, Shields JA, Cater J, Othmane I, Singh AD, Micaily B. Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors. Ophthalmology 2001;108:2116-2121
9. McCaffery S, Wieland MR, O'Brien JM, Cooper KL, Wieland MR, Wendel RT. Atypical retinoblastoma presentations: a challenge for the treating ophthalmologist. Arch Ophthalmol 2002;120:1222-1225
10. Basile AM, Fusi C, Conti AA, Paniccia R, Trefoloni G, Pracucci G, Di Carlo A, Noferi D, Carbonetto F, Pretelli P, Calamai G, Vaccari M, Abbate R, Inzitari D. S-100 protein and neuron-specific enolase as markers of subclinical cerebral damage after cardiac surgery: preliminary observation of a 6-month follow-up study. Eur Neurol 2001;45(3):151-159
11. Agelink MW, Andrich J, Postert T, Würzinger U, Zeit T, Klotz P, Przuntek H. Relation between electroconvulsive therapy, cognitive side effects, neuron specific enolase, and protein S-100. J Neurol Neurosurg Psychiatry 2001;71(3):394-396
12. Ebert W, Muley T, Trainer C, Dienemann H, Drings P. Comparison of changes in the NSE levels with clinical assessment in the therapy monitoring of patients with SCLC. Anticancer Res 2002;22(2):1083-1089
13. Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, Semmes OJ, Schellhammer PF, Yasui Y, Feng Z, Wright GL Jr. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 2002;62:3609-3614
14. Xiao XY, He DC. Development of proteomic patterns for detecting lung cancer. Dis Markers, 2003;19:33-39
15. Yang SY, Xiao XY, Zhang WG, Sun XZ, Zhang LJ, Zhang W, Zhou B, Yang DC, He DC. Application of serum surface-enhanced laser desorption/ionization proteomic patterns in distinguishing non-small cell lung cancer patients from healthy people. Chin J Tuberc Respir Dis 2006; 2:31-34
16. Göbel T, Vorderwülbecke S, Hauck K, Fey H, Häussinger D, Erhardt A. New multi-protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples. World J Gastroenterol 2006;12(47):7604-7612
17. Won Y, Song HJ, Kang TW, Kim JJ, Han BD, Lee SW. Pattern analysis of serum proteome distinguishes renal cell carcinoma from other urologic diseases and healthy persons. Proteomics 2003;3:2310-2316
18. Lee IN, Chen CH, Sheu JC, Lee HS, Huang GT, Chen DS, Yu CY, Wen CL, Lu FJ, Chow LP. Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach. Proteomics 2006; 6(9):2865-2873
19. Pan YZ, Xiao XY, Zhao D, Zhang L, Ji GY, Li Y, He DC, Zhao XJ, Yang BX. Proteomic analysis of prostate cancer using surface enhanced laser desorption/ionization mass spectrometry. Natl Med J China 2005;85: 3172-3175
20. Kanmura S, Uto H, Kusumoto K, Ishida Y, Hasuike S, Nagata K, Hayashi K, Ido A, Stuver SO, Tsubouchi H. Early diagnostic potential for hepatocellular carcinoma using the SELDI ProteinChip system. Hepatology 2007;45(4):948-956
21. Semmes OJ, Feng Z, Adam BL, Banez LL, Bigbee WL, Campos D, Cazares LH, Chan DW, Grizzle WE, Izbicka E, Kagan J, Malik G, McLerran D, Moul JW, Partin A, Prasanna P, Rosenzweig J, Sokoll IJ, Srivastava S, Srivastava S, Thompson I, Welsh MJ, White N, Wingel M, Yasui Y, Zhang Z, Zhu L. Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer. Assessment of Platform Reproducibility. Clin Chem 2005;51:102-112